Cellular Genome-wide Association Study Identifies Common Genetic Variation Influencing Lithium-Induced Neural Progenitor Proliferation-Reference-Cited by-同舟云学术

Cellular Genome-wide Association Study Identifies Common Genetic Variation Influencing Lithium-Induced Neural Progenitor Proliferation

Published:2023-01 Issue:1 Volume:93 Page:8-17
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Wolter Justin M.,Le Brandon D.,Matoba Nana,Lafferty Michael J.,Aygün Nil,Liang Dan,Courtney Kenan,Song Juan,Piven Joseph,Zylka Mark J.,Stein Jason L.^ORCID

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference81 articles.

1. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials;Geddes;Am J Psychiatry,2004

2. The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines;Malhi;J Affect Disord,2017

3. Treatment of bipolar disorder;Geddes;Lancet,2013

4. A population-based heritability estimate of bipolar disorder – In a Swedish twin sample;Johansson;Psychiatry Res,2019

5. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: A 12-month, randomized, double-blind, controlled clinical trial;Tohen;Am J Psychiatry,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probabilistic classification of gene-by-treatment interactions on molecular count phenotypes;2024-08-06

2. Schizophrenia genomics: genetic complexity and functional insights;Nature Reviews Neuroscience;2024-07-19

3. Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models;Translational Psychiatry;2024-06-10

4. A perspective on the application of CRISPR/CAS9 genome editing system to study of molecular-genetic basis of mental disorders;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2024

5. Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study;Schizophrenia;2023-10-14